1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Early Phase 1 | 1 | Terminated 1 |
Follow Exocrine Pancreatic Cancer: new trials by email Literature Review of Exocrine Pancreatic Cancer trials Research Report on Exocrine Pancreatic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Dose Omeprazole in Patients With Pancreatic Cancer Omeprazole - Exocrine Pancreatic Cancer | Early Phase 1 | Terminated | University of Oklahoma | 25 | 2021-09-07 | 2026-06-01 |
| PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors Exocrine Pancreatic Cancer | Recruiting | Centre Leon Berard | 300 | 2020-09-01 | 2026-04-28 | |
| Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors tisotumab vedotin, pembrolizumab, carboplatin - Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 2 | Active not recruiting | Seagen, a wholly owned subsidiary of Pfizer | 350 | 2018-06-25 | 2026-07-22 |
| Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine PCI-27483, Gemcitabine - Pancreatic Cancer, Ductal Adrenocarcinoma | Phase 2 | Completed | Pharmacyclics LLC. | 42 | 2009-11-01 | 2014-04-24 |
Pancreatic Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasm Metastasis (1) · Squamous Cell Carcinoma of Head and Neck (1)
Digestive System Diseases (4) · Digestive System Neoplasms (4) · Endocrine Gland Neoplasms (4) · Endocrine System Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Pancreatic Diseases (4) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Colonic Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1)
Carboplatin (1) · Cisplatin (1) · Gemcitabine (1) · Omeprazole (1) · PCI-27483 (1) · pembrolizumab (1) · tisotumab vedotin (1)
Centre Leon Berard (1) · Pharmacyclics LLC. (1) · Seagen, a wholly owned subsidiary of Pfizer (1) · University of Oklahoma (1)
United States (3) · France (2) · Canada (1) · Germany (1) · Italy (1) · Spain (1) · United Kingdom (1)
Ajay Jain, MD (1) · Eric Hedrick, MD (1) · Laurence Elias, MD (1)
2023 (1)